SEC Form 4 · accession 0001179110-15-011175
IMMUNOGEN INC · IMGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel M Junius
Officer — Chief Executive Officer · Director
Period of report
Jul 13, 2015
Accepted (ET)
Jul 14, 2015 · 10:38 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000855654
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $16.72 | Jul 13, 2015 | A | 205,000 | A | Jul 13, 2016 | Jul 13, 2025 | Common stock | 205,000 | 205,000 | D |
Explanation of responses
- F1Exercisable as to 68,334 shares commencing on July 13, 2016, 68,333 shares commencing on July 13, 2017 and 68,333 shares commencing on July 13, 2018.